Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 55 results for "Chronic Myeloid Leukemia (CML)".

Thumbnail for Blastic Crisis of CML in a Patient With Underlying CLL.

CML - 713

Blastic Crisis of CML in a Patient With Underlying CLL.

Ricardo Romano

Poster Presenter: Ricardo Romano

Thumbnail for Efficacy of Olverembatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) With Prior Resistance to Ponatinib or Asciminib and ASXL1 Mutations

CML - 731

Efficacy of Olverembatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) With Prior Resistance to Ponatinib or Asciminib and ASXL1 Mutations

Elias Jabbour

Poster Presenter: Elias Jabbour

Thumbnail for Comparison of the Incidence of Cardiovascular Adverse Events in Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors With Representatives of the General Population

Previous 1...3 4 5 6 7 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

CML - 797

Comparison of the Incidence of Cardiovascular Adverse Events in Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors With Representatives of the General Population

Nadezhda Shnalieva

Poster Presenter: Nadezhda Shnalieva

Thumbnail for Mutation analysis of ABL kinase domain in Tunisian CML patients treated with tyrosine kinase inhibitors

CML - 899

Mutation analysis of ABL kinase domain in Tunisian CML patients treated with tyrosine kinase inhibitors

Rim Frikha

Poster Presenter: Rim Frikha

Thumbnail for Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

CML - 913

Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

Ali Turunc

Poster Presenter: Ali Turunc

Thumbnail for Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

CML - 918

Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

Moshe Levy

Poster Presenter: Moshe Levy

Thumbnail for Comparable Survival, Divergent Mortality: Five-Year Outcomes of Chronic Myeloid Leukemia in a Peruvian Public Hospital

CML - 926

Comparable Survival, Divergent Mortality: Five-Year Outcomes of Chronic Myeloid Leukemia in a Peruvian Public Hospital

Cesar Copaja-Corzo

Poster Presenter: Cesar Copaja-Corzo

Thumbnail for Validation of a Prognostic Score in Blast Phase CML: A Cure CML Consortium Analysis

CML - 929

Validation of a Prognostic Score in Blast Phase CML: A Cure CML Consortium Analysis

Akriti G Jain

Poster Presenter: Akriti G Jain

Thumbnail for Treatment Response of Dasatanib in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients

CML - 969

Treatment Response of Dasatanib in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients

Baalamurugan K T

Poster Presenter: Baalamurugan K T